CG Oncology Reports Third-Quarter 2026 Financial Results
CG Oncology reported third-quarter 2026 financial results and provided business updates.
Related stories
SunCar Technology Group to Buy Back Up to $10 Million of Shares
SunCar Technology Group plans to buy back up to $10 million of its outstanding Class A ordinary shares.
L impact | EQUITY | Nov 06, 2026, 02:35 PM UTC
Charter Targets $2 Billion in Annualized Cost Savings
Charter Communications is starting a cost-cutting plan targeting about $2 billion in annualized run-rate operating expense savings over the next year and a half.
M impact | EQUITY | Nov 06, 2026, 02:35 PM UTC
Cloudflare Shares Jump 17% In Biggest Gain Since April 2025
L impact | EQUITY | Nov 06, 2026, 02:35 PM UTC
Airbnb Shares Rise 13% In Biggest Jump Since Aug 7th
L impact | EQUITY | Nov 06, 2026, 02:34 PM UTC
Lam Research Shares Up 10.1% After Announcing USD 25B Buyback
L impact | EQUITY | Nov 06, 2026, 02:34 PM UTC
Sunstone Hotel Investors Reports Q3 Results, Raises 2026 FFO Guidance
Sunstone reported revenue of $233.7 million and adjusted FFO of $0.20 per share for the third quarter of 2026. It raised 2026 adjusted FFO per-share guidance to $1.00–$1.03.
M impact | EQUITY | Nov 06, 2026, 02:33 PM UTC